Form D · Pharmaceuticals
Kardiatonos, Inc.
Metamora, MI · CIK 0001658983
Offering snapshot reported Nov 23, 2015 · SEC filing
- Reported sold
- $25K Offering amount: $750K
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $25K Reported outside-investor minimum
- First sale
- Nov 4, 2015 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Nov 23, 2015 | Initial | $25,000 | No comparison | 1 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-251710
Source: Form D, filed Nov 23, 2015. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| James W Cocco | Executive |
| Nicholas A Cocco | Director, Executive |
| Sandra M. Kiesel Vander Laan | Executive |
| Kenneth I Kohn | Director, Executive |
| William P Ruffa | Executive |
| Josephino B Tunac | Director, Executive |
| Paul H Wooley | Executive |
Issuer details
Industry: Pharmaceuticals (See others in industry)
Address:
4909 South Lapeer Road
Metamora, MI, 48455
Metamora, MI, 48455